FTRP

6-K - Reunion Neuroscience Inc. (0001865482) (Filer)

6-K - Reunion Neuroscience Inc. (0001865482) (Filer)

6-K - Reunion Neuroscience Inc. (0001865482) (Filer)

S-8 - Reunion Neuroscience Inc. (0001865482) (Filer)

6-K - Reunion Neuroscience Inc. (0001865482) (Filer)

SUPPL - Reunion Neuroscience Inc. (0001865482) (Filer)

6-K - Reunion Neuroscience Inc. (0001865482) (Filer)

6-K - Reunion Neuroscience Inc. (0001865482) (Filer)

6-K - Reunion Neuroscience Inc. (0001865482) (Filer)

Field Trip (NASDAQ:FTRP), Wesana (OTCQB:WSNAF), Braxia (OTC:BRAXF) and Irwin Naturals (OTC: IWINF) released their quarterly results. Field Trip Health & Wellness Ltd.  Psychedelic-assisted therapy provider Field Trip (TSXV:FTHW) reported its fiscal and business results for the three-month period ended June 30, 2022. The company recently split into two new public companies to separate drug development on one hand, and healthcare and wellness on the other: Field Trip Discovery and Field Trip Health, which are now called Reunion Neuroscience Inc. and Field Trip Health & Wellness (or Field Trip alone).  The latter’s financial results for the three months ended June 30, 2022 are the following

  GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 4.17% at $0.35 Cybin (AMEX:CYBN) shares closed up 1.94% at $0.77 ATAI Life Sciences (NASDAQ:ATAI) shares closed up 1.92% at $4.77 Field Trip Health (NASDAQ:FTRP) shares closed up 1.07% at $0.84 LOSERS: GH Research (NASDAQ:GHRS) shares closed down 9.37% at $12.09 Allied (OTC:ALID) shares closed down 8.33% at $0.44 Seelos Therapeutics (NASDAQ:SEEL) shares closed down 5.28% at $0.92 Numinus Wellness (OTC:NUMIF) shares closed down 2.96% at $0.23 Compass Pathways (NASDAQ:CMPS) shares closed down 2.91% at $17.37 Mind Medicine (NASDAQ:MNMD) shares closed down 2.86% at $0.68 Biomind Labs (OTC:BMNDF) shares closed down 0.00

TORONTO, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (formerly, Field Trip Health Ltd., the "Company" or "Reunion"), a global leader in the discovery and development of innovative of psychedelic-inspired therapeutics for improved mental health outcomes, is pleased to announce that its common shares (the "Shares") will commence trading on the Toronto Stock Exchange ("TSX") under the ticker symbol "REUN" at the opening of the market on August 17, 2022. Trading of the Company's shares on the TSX represents the last step in the corporate reorganization that resulted in the spinout of the Company's former subsidiary, Field Trip Health & Wellness Ltd. ("FTHW") into a stand-alone

6-K - Reunion Neuroscience Inc. (0001865482) (Filer)

6-K - Reunion Neuroscience Inc. (0001865482) (Filer)

Completed corporate reorganization, separating the Field Trip Discovery and Field Trip Health divisions into two separate companies.Field Trip Discovery renamed Reunion Neuroscience Inc. ("Reunion" or the "Company"), and will remain listed on the NASDAQ Stock Market and Toronto Stock Exchange under new ticker symbol "REUN".Field Trip Health renamed Field Trip Health & Wellness Ltd. ("Field Trip H&W") and has received listing approval from the Toronto Stock Exchange Venture under new ticker symbol "FTHW".First day of trading for both Reunion and Field Trip H&W is August 17, 2022.On July 21, 2022, announced successful first dosings in the Company's Phase 1 Clinical Study of its first novel psy

  GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 2.70% at $0.98 ATAI Life Sciences (NASDAQ:ATAI) shares closed up 2.18% at $4.68 Revive Therapeutics (OTC:RVVTF) shares closed up 1.82% at $0.34 LOSERS: Allied (OTC:ALID) shares closed down 12.73% at $0.48 Cybin (AMEX:CYBN) shares closed down 6.21% at $0.75 Numinus Wellness (OTC:NUMIF) shares closed down 4.78% at $0.24 Mind Medicine (NASDAQ:MNMD) shares closed down 3.53% at $0.70 Compass Pathways (NASDAQ:CMPS) shares closed down 2.53% at $17.89 Field Trip Health (NASDAQ:FTRP) shares closed down 1.98% at $0.83 Biomind Labs (OTC:BMNDF) shares closed down 0.00% at $0.75 GH Research (NASDAQ:GHRS) shares closed down 0.

  Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter. • GreenPower Motor Co (NASDAQ:GP) is estimated to report quarterly loss at $0.15 per share on revenue of $5.59 million. • Mondee Hldgs (NASDAQ:MOND) is likely to report quarterly loss at $0.04 per share on revenue of $38.94 million. • Reshape Lifesciences (NASDAQ:RSLS) is expected to report quarterly loss at $0.35 per share on revenue of $3.41 million. • Alaunos Therapeutics (NASDAQ:TCRT) is expected to report earnings for its second quarter. • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $0.19 per share on revenue of $5.25 million. • IM Cannab

  GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 11.58% at $0.73 Numinus Wellness (OTC:NUMIF) shares closed up 11.53% at $0.25 Allied (OTC:ALID) shares closed up 7.84% at $0.55 Compass Pathways (NASDAQ:CMPS) shares closed up 5.91% at $18.36 GH Research (NASDAQ:GHRS) shares closed up 5.79% at $13.33 Seelos Therapeutics (NASDAQ:SEEL) shares closed up 4.79% at $0.95 ATAI Life Sciences (NASDAQ:ATAI) shares closed up 3.39% at $4.58 Revive Therapeutics (OTC:RVVTF) shares closed up 3.13% at $0.33 LOSERS: Cybin (AMEX:CYBN) shares closed down 6.60% at $0.80 Field Trip Health (NASDAQ:FTRP) shares closed down 0.00% at $0.85 Biomind Labs (OTC:BMNDF) shares closed down 0.00% at $

- Field Trip Health Ltd. has been renamed "Reunion Neuroscience Inc." and remains listed on the NASDAQ Stock Market and Toronto Stock Exchange under the ticker symbol "FTRP" with such ticker symbol changing to "REUN" - Field Trip Health & Wellness Ltd. to be listed on the TSX Venture Exchange under ticker symbol “FTHW” - First day of trading for both Reunion and Field Trip Health & Wellness expected to occur on or about August 17, 2022 - Field Trip Health & Wellness Ltd. completes $19.9 million private placement financing

  GAINERS: Allied (OTC:ALID) shares closed up 6.25% at $0.51 GH Research (NASDAQ:GHRS) shares closed up 2.19% at $12.60 Numinus Wellness (OTC:NUMIF) shares closed up 1.68% at $0.22 LOSERS: Compass Pathways (NASDAQ:CMPS) shares closed down 12.16% at $17.33 Revive Therapeutics (OTC:RVVTF) shares closed down 9.86% at $0.32 ATAI Life Sciences (NASDAQ:ATAI) shares closed down 5.34% at $4.43 Seelos Therapeutics (NASDAQ:SEEL) shares closed down 2.53% at $0.91 Mind Medicine (NASDAQ:MNMD) shares closed down 0.21% at $0.65 Biomind Labs (OTC:BMNDF) shares closed down 0.00% at $0.75 Field Trip Health (NASDAQ:FTRP) shares closed down 0.58% at $0.85 Cybin (AMEX:CYBN) shares closed down 0

- Field Trip Health Ltd. has been renamed "Reunion Neuroscience Inc." and remains listed on the NASDAQ Stock Market and Toronto Stock Exchange under the ticker symbol "FTRP" with such ticker symbol changing to "REUN"- Field Trip Health & Wellness Ltd. to be listed on the TSX Venture Exchange under ticker symbol "FTHW" - First day of trading for both Reunion and Field Trip Health & Wellness expected to occur on or about August 17, 2022 - Field Trip Health & Wellness Ltd. completes $19.9 million private placement financing TORONTO, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc., (formerly, Field Trip Health Ltd.) (TSX:FTRP, NASDAQ:FTRP) (the "Company"), and Field Trip Health &

  GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 12.32% at $0.65 GH Research (NASDAQ:GHRS) shares closed up 10.02% at $12.74 Cybin (AMEX:CYBN) shares closed up 7.57% at $0.85 ATAI Life Sciences (NASDAQ:ATAI) shares closed up 6.12% at $4.68 Seelos Therapeutics (NASDAQ:SEEL) shares closed up 4.52% at $0.93 Compass Pathways (NASDAQ:CMPS) shares closed up 4.17% at $19.73 Revive Therapeutics (OTC:RVVTF) shares closed up 1.43% at $0.35 Allied (OTC:ALID) shares closed up 1.05% at $0.48 LOSERS: Numinus Wellness (OTC:NUMIF) shares closed down 2.48% at $0.22 Field Trip Health (NASDAQ:FTRP) shares closed down 0.58% at $0.85 Biomind Labs (OTC:BMNDF) shares closed down 0.00% at $

  GAINERS: Cybin (AMEX:CYBN) shares closed up 10.35% at $0.79 Field Trip Health (NASDAQ:FTRP) shares closed up 6.25% at $0.85 Allied (OTC:ALID) shares closed up 1.06% at $0.47   LOSERS: Numinus Wellness (OTC:NUMIF) shares closed down 5.09% at $0.23 Compass Pathways (NASDAQ:CMPS) shares closed down 3.56% at $18.94 GH Research (NASDAQ:GHRS) shares closed down 3.50% at $11.58 Revive Therapeutics (OTC:RVVTF) shares closed down 2.80% at $0.35 Mind Medicine (NASDAQ:MNMD) shares closed down 1.68% at $0.58 Seelos Therapeutics (NASDAQ:SEEL) shares closed down 1.16% at $0.89 ATAI Life Sciences (NASDAQ:ATAI) shares closed down 0.45% at $4.41 Biomind Labs (OTC:BMNDF) shares closed dow

TORONTO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX:FTRP, NASDAQ:FTRP) ("Field Trip" or the "Company"), a global leader in the development and delivery of psychedelic therapies, announced today that it plans to release financial results for its fiscal 2023 first quarter for the three-month period ended June 30, 2022, after market close on Monday, August 15, 2022. The Company will conduct a conference call and webcast to discuss its results the following morning, Tuesday, August 16, 2022 at 8:30 a.m. ET. To access the call, please dial 1-877-407-9716 (within the U.S.) or 1-201-493-6779 (outside the U.S.) and provide conference ID 13731900. A live webcast of the conferenc

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 29.83% at $15.80 Numinus Wellness (OTC:NUMIF) shares closed up 16.20% at $0.26 Cybin (AMEX:CYBN) shares closed up 14.94% at $0.71 Compass Pathways (NASDAQ:CMPS) shares closed up 14.69% at $20.07 ATAI Life Sciences (NASDAQ:ATAI) shares closed up 6.57% at $4.38 Revive Therapeutics (OTC:RVVTF) shares closed up 4.63% at $0.36 Seelos Therapeutics (NASDAQ:SEEL) shares closed up 2.84% at $1.00 Field Trip Health (NASDAQ:FTRP) shares closed up 1.12% at $0.84 LOSERS: Mind Medicine (NASDAQ:MNMD) shares closed down 12.15% at $0.62 Allied (OTC:ALID) shares closed down 0.00% at $0.52 Biomind Labs (OTC:BMNDF) shares closed down 0.00% at $